Atorvastatin and celecoxib in combination inhibits the progression of androgen-dependent LNCaP xenograft prostate tumors to androgen independence
about
Statin use and risk of prostate cancer: a meta-analysis of observational studiesInhibition of proliferation and induction of autophagy by atorvastatin in PC3 prostate cancer cells correlate with downregulation of Bcl2 and upregulation of miR-182 and p21.Inhibitory effect of dietary atorvastatin and celecoxib together with voluntary running wheel exercise on the progression of androgen-dependent LNCaP prostate tumors to androgen independenceAtorvastatin Treatment for Atrial Fibrillation Reduces Serum High-Sensitivity C-Reactive Protein LevelsHemostatic gelatin sponge is a superior matrix to matrigel for establishment of LNCaP human prostate cancer in nude miceNew players for advanced prostate cancer and the rationalisation of insulin-sensitising medicationFuture directions in the prevention of prostate cancer.Combination of Lipitor and Celebrex inhibits prostate cancer VCaP cells in vitro and in vivo.Inhibition of IL-6 expression in LNCaP prostate cancer cells by a combination of atorvastatin and celecoxib.Nonsteroidal anti-inflammatory drugs and prostatic diseasesHitting the Bull's-Eye in Metastatic Cancers-NSAIDs Elevate ROS in Mitochondria, Inducing Malignant Cell Death.Synergistic chemopreventive effects of nobiletin and atorvastatin on colon carcinogenesis.Evidence for Feedback Regulation Following Cholesterol Lowering Therapy in a Prostate Cancer Xenograft Model.Oral simvastatin administration delays castration-resistant progression and reduces intratumoral steroidogenesis of LNCaP prostate cancer xenografts.Statin Use at the Time of Initiation of Androgen Deprivation Therapy and Time to Progression in Patients With Hormone-Sensitive Prostate Cancer.Inhibition of progression of androgen-dependent prostate LNCaP tumors to androgen independence in SCID mice by oral caffeine and voluntary exercise.The preventative effects of sunitinib malate observed in the course from non-castration to castration LNCaP xenograft prostate tumors.Down-regulation of calcium/calmodulin-dependent protein kinase kinase 2 by androgen deprivation induces castration-resistant prostate cancer.The association of statins and taxanes: an efficient combination trigger of cancer cell apoptosis.Regression of prostate tumors upon combination of hormone ablation therapy and celecoxib in vivo.Marketed drugs used for the management of hypercholesterolemia as anticancer armament.Inhibitory Effect of a γ-Tocopherol-Rich Mixture of Tocopherols on the Formation and Growth of LNCaP Prostate Tumors in Immunodeficient Mice.Mechanisms of colitis-accelerated colon carcinogenesis and its prevention with the combination of aspirin and curcumin: Transcriptomic analysis using RNA-seq.Atorvastatin attenuates testosterone-induced benign prostatic hyperplasia in rats: role of peroxisome proliferator-activated receptor-γ and cyclo-oxygenase-2.Chemopreventative celecoxib fails to prevent schwannoma formation or sensorineural hearing loss in genetically engineered murine model of neurofibromatosis type 2.
P2860
Q21133952-43567132-37B1-4C85-A138-48A7E2682A52Q34925849-DA27B850-9779-437D-8994-2CCD7D3D18BDQ35030507-E2F36D3C-AF32-4415-B9E5-8A07269967C7Q35851578-BF3FF2D4-28C3-4334-B727-6354CCC79401Q36243387-2CB566C1-D51F-4754-9F64-6C717968709DQ36734036-8CB637D3-840C-4B14-A9DE-7EEE60C99127Q37279094-E63959CE-D34A-4BFB-BDF4-46BDFB9BB564Q37596358-93935CE9-3FB5-439F-9A96-AFD3697CA5D0Q37694029-33DA3901-F7B9-4C38-BFB7-5B38B70D59CFQ38217858-A2CCA9D6-3E5D-490B-8EF8-87E3DD457D87Q38358175-D10AA917-A655-46C2-A6C4-0F3506ABCF2AQ38716191-51B42A3D-223D-49BC-9265-79FF0148E82BQ38728309-7B454367-1B85-459F-80FD-76C2E3B44B2DQ38846889-D4204378-C751-45A1-9955-FBCABC5D5D09Q38852322-4254C1F4-7BE1-4B1A-A4A8-0DCEE25E02C3Q39260494-B3F0D0F2-CA93-4D39-ADBB-5C8C02442071Q39301529-5E4F6227-9B55-45AD-9ACC-1F3B6C0A29E4Q39355407-87DAD7F5-10A4-46B5-BBF3-0964BBE6C1ABQ39403423-BF49AF62-2BEC-45E7-82CA-A81A520F5F18Q39566592-FD55B31C-46AB-40DF-B946-D1A21F0E65DAQ41080847-32DBE8A3-5A46-4EF3-B383-402393DF3FC0Q42240662-1F8513E7-5904-405A-8292-9A1FEF00AFCFQ42775899-A8573149-37E5-43A6-9748-26FD9116045CQ48242893-82EC6528-0B5F-4E47-81F5-1EDC69A594DFQ49876859-06EF3D7F-D4A7-4DE0-BD80-2611E7D39EB0
P2860
Atorvastatin and celecoxib in combination inhibits the progression of androgen-dependent LNCaP xenograft prostate tumors to androgen independence
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Atorvastatin and celecoxib in ...... umors to androgen independence
@ast
Atorvastatin and celecoxib in ...... umors to androgen independence
@en
Atorvastatin and celecoxib in ...... mors to androgen independence.
@nl
type
label
Atorvastatin and celecoxib in ...... umors to androgen independence
@ast
Atorvastatin and celecoxib in ...... umors to androgen independence
@en
Atorvastatin and celecoxib in ...... mors to androgen independence.
@nl
prefLabel
Atorvastatin and celecoxib in ...... umors to androgen independence
@ast
Atorvastatin and celecoxib in ...... umors to androgen independence
@en
Atorvastatin and celecoxib in ...... mors to androgen independence.
@nl
P2093
P2860
P1476
Atorvastatin and celecoxib in ...... umors to androgen independence
@en
P2093
Allan H Conney
Arnold Rabson
Bandaru Reddy
Chung S Yang
Mou-Tuan Huang
Weichung Joe Shih
Xiao-Xing Cui
P2860
P304
P356
10.1158/1940-6207.CAPR-09-0059
P577
2010-01-01T00:00:00Z